Metabolomic Diagnostics are excited to be part of Med In Ireland this Thursday, 10th October at the RDS, Dublin

Organised by Enterprise Ireland, Med in Ireland brings together innovative Irish medtech companies with healthcare providers and manufacturing partners from around the world. More than 800 executives from the global medical technology and healthcare sectors will attend this invite-only event.  Doing business is central to its success, which brings together senior executives from leading medtech companies and healthcare systems globally and connects them to leading edge innovation from Ireland.

Metabolomic Diagnostics is a biomarker-based diagnostics company based in Cork, Ireland and is focused on developing a portfolio of early pregnancy screening test. The company’s first product, PrePsia™, is focused on Pre-term Preeclampsia screening for first time pregnancies which is an unmet clinical need. This is a serious disease that can cause major disruption during pregnancy leading to the deaths of Mums and Babies and can have serious life-long consequences for the survivors.

 

MED IN IRELAND, RDS, DUBLIN

Experience the future of MedTech

10th OCTOBER 2019

https://medinireland.ie/